OTC : APNHY
-$0.38 (-4.02%)
OTC
Stephen Saad
Drug Manufacturers - Specialty & Generic
Healthcare
APNHY
9557
ZA
USD
0.41
3.64
2.66
0.36
-0.47
$43.36B
1.68
0.80
14.58
9.95
-$2.44
-$1.08B
-5.19%
-5.59%
-2.41%
-1.56%
-32.21
0.31
0.31
2/5
0 Analysts
%
2.12
5/9
$41.52B
$127.92B
$46.91B
$8.94B
$96.15B
2.50
53.27
3.64
-2.41%
5.32%
-2.90%
6.43%
132 days
| Name | Title |
|---|---|
| Luresha Chetty | Corporate Affairs & Investor Relations Executive |
| Sibongakonke Nkosi | Investor Relations Manager |
| Sean Capazorio | Group Chief Financial Officer & Executive Director |
| Stephen Bradley Saad | Group Chief Executive Officer & Executive Director |
| Trevor Julian Ziman | Regional Chief Executive Officer of Asia Pacific |
| Michael Guy Attridge | Group Chief Advisor |
| Reginald Haman PGDBA | Group Chief Corporate Officer |
| Samer Kassem | Chief Executive Officer of Aspen Global Incorporated |
| Raeesa Khan | Group Company Secretary & Chief of Staff |
| Lorraine Hill | Group Chief Operations Officer |
No votes yet today — be the first to share your view!
About Aspen Pharmacare Holdings Limited (OTC:APNHY) Stock
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Ly ... rica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript
2026-05-29 11:14:06
Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript
Frequently Asked Questions
What is the current Aspen Pharmacare Holdings Limited (APNHY) stock price?
Aspen Pharmacare Holdings Limited(OTC:APNHY) stock price is $9.07 in the last trading session. During the trading session, APNHY stock reached the peak price of $9.45 while $5.24 was the lowest point it dropped to. The percentage change in APNHY stock occurred in the recent session was --4.02% while the dollar amount for the price change in APNHY stock was -$0.38.
APNHY's industry and sector of operation?
The OTC listed APNHY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of APNHY?
Luresha Chetty
| Corporate Affairs & Investor Relations Executive
Sibongakonke Nkosi
| Investor Relations Manager
Sean Capazorio
| Group Chief Financial Officer & Executive Director
Stephen Bradley Saad
| Group Chief Executive Officer & Executive Director
Trevor Julian Ziman
| Regional Chief Executive Officer of Asia Pacific
How many employees does APNHY have?
Number of APNHY employees currently stands at 9557. APNHY operates from Aspen Place, Durban, NL 2191, ZA.
Link for APNHY official website?
Official Website of APNHY is: https://www.aspenpharma.com
How do I contact APNHY?
APNHY could be contacted at phone #27 31 580 8600 and can also be accessed through its website. APNHY operates from Aspen Place, Durban, NL 2191, ZA.
How many shares of APNHY are traded daily?
The average number of APNHY shares traded daily for last 3 months was 196.
What is the market cap of APNHY currently?
The market value of APNHY currently stands at $4.03B with its latest stock price at $9.07